It was determined that while treatment significantly reduced tumor viability [Figs. 1(a)–1(c), 11.6 ± 6.71% GE10 vs 100% control, p < 0.01] and the Ki67 index [Figs. 1(d)–1(f), 0.052 ± 0.036 GE10 vs 0.249 ± 0.018 control, p < 0.01], an analog for proliferation, the treatment had not significantly reduced the MVD in the remaining viable tumor tissue [Figs. 1(g)–1(I), p = 0.14]. Here, MKI67 is linked to neoplasm.